# EDGAR Filing Document

**Accession Number:** 0001824293
**File Stem:** 0001824293-26-000036
**Filing Date:** 2026-1
**Character Count:** 2684
**Document Hash:** ad01cb333ce6ca224f4ac4f0d9f3a376
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001824293-26-000036.hdr.sgml**: 20260422

**ACCESSION NUMBER**: 0001824293-26-000036

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GRI Bio, Inc.
- **CENTRAL INDEX KEY:** 0001824293
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 824369909
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2223 AVENIDA DE LA PLAYA
- **STREET 2:** SUITE 208
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037
- **BUSINESS PHONE:** (619) 400-1171

**MAIL ADDRESS:**
- **STREET 1:** 2223 AVENIDA DE LA PLAYA
- **STREET 2:** SUITE 208
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRI BIO, Inc.
- **DATE OF NAME CHANGE:** 20230424

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vallon Pharmaceuticals, Inc.
- **DATE OF NAME CHANGE:** 20200910

**GRI BIO, INC.**

**2223 AVENIDA DE LA PLAYA, SUITE 208**

**LA JOLLA, CA 92037**

January 30, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Chris Edwards

---

| | |
|:---|:---|
| **Re:** | **GRI Bio, Inc.** |
| | **Registration Statement on Form S-3** |
| | **Filed January 30, 2026** |
| | **File No. 333-293065 (the "Registration Statement")** |
| | **<u>Acceleration Request</u>** |

---

Ladies and Gentlemen:

In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, GRI Bio, Inc. (the "Registrant") hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, January 30, 2026, at 4:05 p.m., Eastern Time, or as soon as thereafter practicable.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please contact Melanie Ruthrauff Levy or Jessica Zhang of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (858) 314-1873 or (415) 432-6119, respectively, with any questions regarding this request.

---

| |
|:---|
| Very truly yours, |
| GRI BIO, INC. |
| /s/ W. Marc Hertz, Ph.D. |
| W. Marc Hertz, Ph.D., Chief Executive Officer |

---

---

| | |
|:---|:---|
| cc: | *<u>Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C</u>.* |
| | Adam Lenain, Esq. |
| | Melanie Ruthrauff Levy, Esq. |
| | Jessica Zhang, Esq. |

---

<br>